GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scandinavian Medical Solutions A/S SMSMED.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

2.69

-3.24%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in DKK, from our data supplier.

FY2025

Revenue

DKK 245.4m

FY2019FY2025

Net income

DKK 26,000

FY2019FY2025

Free cash flow

−DKK 34.2m

FY2019FY2025

Shareholders' equity

DKK 82.7m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueDKK 245.4mDKK 226.7mDKK 191.2mDKK 110.5mDKK 71.6mDKK 41.9mDKK 31.2m
Gross profitDKK 34.3mDKK 40.1mDKK 34.7mDKK 22.7mDKK 13.9mDKK 7.4mDKK 4.8m
Operating incomeDKK 1.8mDKK 13.8mDKK 16.6mDKK 14.7mDKK 10.9mDKK 6.0mDKK 3.9m
Net incomeDKK 26,000DKK 7.8mDKK 12.2mDKK 11.4mDKK 8.2mDKK 4.5mDKK 3.0m
Diluted earnings per share0.000.280.450.420.3145.110.11

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsDKK 205.9mDKK 174.1mDKK 164.0mDKK 106.1mDKK 44.6mDKK 17.1mDKK 9.4m
Cash and short-term investmentsDKK 2.1mDKK 11.0mDKK 7.9mDKK 27.8mDKK 25.4mDKK 10.7mDKK 4.1m
Total liabilitiesDKK 123.2mDKK 91.6mDKK 89.5mDKK 43.9mDKK 20.5mDKK 12.2mDKK 6.2m
DebtDKK 63.5mDKK 39.2mDKK 28.6mDKK 105,558—DKK 302,405DKK 104,780
Shareholders' equityDKK 82.7mDKK 82.5mDKK 74.5mDKK 62.2mDKK 24.1mDKK 4.9mDKK 3.1m
Shares outstanding28m28m27m27m26m0m27m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−DKK 13.4mDKK 3.4m−DKK 8.4m−DKK 10.6mDKK 4.0mDKK 9.4m—
Capital spending−DKK 20.8m−DKK 18.5m−DKK 40.8m−DKK 13.8m−DKK 5−DKK 13.8m—
Free cash flow−DKK 34.2m−DKK 15.1m−DKK 49.2m−DKK 24.3mDKK 4.0m−DKK 4.4m—
Dividends paid————−DKK 4.5m——

Latest quarters

By quarter end

Mar 2026Sept 2025Mar 2025Sept 2024Mar 2024Dec 2023Sept 2023Jun 2023
RevenueDKK 92.3mDKK 122.7mDKK 122.7mDKK 124.1mDKK 102.6mDKK 51.3mDKK 95.0mDKK 47.5m
Gross profit−DKK 1.4mDKK 16.1mDKK 12.5mDKK 17.3mDKK 13.1mDKK 8.7mDKK 12.7mDKK 6.9m
Operating income−DKK 12.0mDKK 5.3m−DKK 3.4mDKK 9.2mDKK 4.6mDKK 2.3mDKK 3.9mDKK 2.0m
Net income−DKK 10.0mDKK 2.4m−DKK 2.3mDKK 5.2mDKK 2.6mDKK 1.3mDKK 2.7mDKK 1.4m
Diluted earnings per share-0.360.09-0.080.190.100.050.100.05
Cash from operations−DKK 2.0m−DKK 1.0m−DKK 11.0mDKK 17.0m−DKK 14.0m−DKK 7.0mDKK 2.0mDKK 1.0m
Capital spending−DKK 8.0m−DKK 10.0m−DKK 10.0m−DKK 15.0m−DKK 3.0m−DKK 1.0m−DKK 26.0m−DKK 13.0m
Free cash flow−DKK 10.0m−DKK 11.0m−DKK 21.0mDKK 2.0m−DKK 17.0m−DKK 8.0m−DKK 24.0m−DKK 12.0m
Total assetsDKK 196.7mDKK 205.9mDKK 181.7mDKK 174.1mDKK 164.2mDKK 164.2mDKK 164.0mDKK 164.0m
Cash and short-term investmentsDKK 1.4mDKK 2.1mDKK 574,000DKK 11.0mDKK 6.1mDKK 6.1mDKK 7.9mDKK 7.9m
DebtDKK 38.9mDKK 33.2mDKK 19.1mDKK 25.9mDKK 25.3mDKK 25.3mDKK 10.9mDKK 10.9m
Shareholders' equityDKK 72.8mDKK 82.7mDKK 80.4mDKK 82.5mDKK 77.3mDKK 77.3mDKK 74.5mDKK 74.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue30.2%42.3%—
Operating income-50.5%-21.4%—
Net income-86.8%-64.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin15.8%17.0%17.2%—
Operating margin3.3%6.1%7.2%—
Net margin1.7%4.1%5.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings—21.116.616.516.7
Price to sales0.50.71.11.71.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.